Workflow
CONMED (CNMD)
icon
Search documents
CONMED (CNMD) - 2022 Q4 - Annual Report
2023-02-20 16:00
Common Stock, $0.01 par value CNMD NYSE Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorte ...
CONMED (CNMD) - 2022 Q4 - Earnings Call Transcript
2023-02-03 00:45
CONMED Corporation (NYSE:CNMD) Q4 2022 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Robbie Marcus - JPMorgan Rick Wise - Stifel Matt O'Brien - Piper Sandler Young Li - Jefferies Mike Matson - Needham Matthew Mishan - KeyBanc Operator Good afternoon, everyone. Before the ...
CONMED (CNMD) Investor Presentation - Slideshow
2022-11-21 15:06
Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer November 15, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's ...
CONMED (CNMD) - 2022 Q3 - Earnings Call Transcript
2022-10-27 01:33
CONMED Corporation (NYSE:CNMD) Q3 2022 Earnings Conference Call October 26, 2022 4:30 PM ET Company Representatives Curt Hartman - Chair of the Board, President, Chief Executive Officer Todd Garner - Executive Vice President, Chief Financial Officer Conference Call Participants Mike Matson - Needham Young Li - Jefferies Robbie Marcus - J.P. Morgan Matthew Mishan - KeyBanc Matt O'Brien - Piper Sandler Rick Wise - Stifel Travis Steed - Bank of America Securities Operator Good afternoon, everyone. Before the c ...
CONMED (CNMD) - 2022 Q3 - Earnings Call Presentation
2022-10-26 23:55
Investor Presentation Q3 2022 Earnings Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer October 26, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate ...
CONMED (CNMD) - 2022 Q3 - Quarterly Report
2022-10-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...
CONMED (CNMD) - 2022 Q2 - Earnings Call Transcript
2022-07-28 00:59
CONMED Corporation (NYSE:CNMD) Q2 2022 Earnings Conference Call July 27, 2022 4:30 PM ET Company Participants Curt Hartman - Chairman, President & Chief Executive Officer Pat Beyer - President, CONMED International & Global Orthopaedics Todd Garner - Executive Vice President & Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - JPMorgan Travis Steed - Bank of America Mike Matson - Needham & Company Matt O'Brien - Piper Sandler Matthew Mishan - KeyBanc Capital Operator Goo ...
CONMED (CNMD) - 2022 Q2 - Earnings Call Presentation
2022-07-27 23:05
Investor Presentation Q2 2022 Earnings Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer July 27, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to ...
CONMED (CNMD) - 2022 Q2 - Quarterly Report
2022-07-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...
CONMED (CNMD) - 2022 Q1 - Earnings Call Transcript
2022-05-08 09:20
Conmed Corp (NYSE:CNMD) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Curt Hartman - Chairman, CEO & President Todd Garner - EVP & CFO Conference Call Participants Lilia-Celine Breton Lozada - JPMorgan Chase & Co. Rick Wise - Stifel, Nicolaus & Company Michael Matson - Needham & Company Matthew Mishan - KeyBanc Capital Markets Operator Good day, and thank you for standing by. Welcome to the First Quarter Fiscal Year '22 CONMED Earnings Conference Call. [Operator Instructions]. ...